Clinically Studied Vemma Formula
The Vemma Clinical Trials were conducted by one of the
industry's most widely-recognized experts in Independent
Clinical Testing, Brunswick Laboratories in Norton, MA.
The intention of these studies was to evaluate the efficacy
and overall bioavailability of a mangosteen product containing
multivitamins, essential minerals and antioxidants (Vemma) on
immune function and well-being in adults. This was done by subjecting
the product to the gold standard of clinical research, the independent
double-blind, placebo controlled study that follows a specific set of
procedures to ensure that the results are dependable and free from
bias. The studies confirmed Vemma showed significant improvements in
immune markers, superior antioxidant absorption and a lowering of
C-reactive Protein (CRP), which points to it's beneficial effects on
overall health and wellness.*
– Yibing Wang, M.D., Ph.D."The studies you are about to read give credence to the countless positive testimonials Vemma has received from customers over the years on its ability to help overcome challenges, increase vitality and enhance well-being.*"
Effect of Mangosteen Dietary Supplement on Human Immune Function: A Randomized, Double-Blind, Placebo-Controlled Trial
Journal of Medicinal Food,
August 2009 Issue
The purpose of the first independent randomized, double blind placebo study evaluated how Vemma enhanced immune function and well-being in humans.* Participants were randomly divided into two groups and received 2 ounces of Vemma or placebo each morning for 30 days. After the 30-day evaluation, the study showed favorable results in immune markers and a lowering of C-reactive protein (CRP) while taking Vemma.*
Changes in IL-1α Concentration (Immunity Marker)
The Vemma group improved their immune function in a statistically significant way.
Changes in IL-1α Concentration (Immunity Marker)
The Vemma group improved their immune function in a statistically significant way.
C-reactive Protein (CRP) is Reduced
in Vemma Participants
Red shaded area indicates high risk range (<1mg/L) of CRP levels. White area is low risk range of CRP levels. The Vemma group was the only group to reduce their CRP levels from unhealthy to healthy levels.
C-reactive Protein (CRP) is Reduced
in Vemma Participants
Red shaded area indicates high risk range (<1mg/L) of CRP levels. White area is low risk range of CRP levels. The Vemma group was the only group to reduce their CRP levels from unhealthy to healthy levels.
Self Reported Health Status
100% of the Vemma group reported that they felt improvement in their health, significantly more than the control group.
Self Reported Health Status
100% of the Vemma group reported that they felt improvement in their health, significantly more than the control group.
Bioavailability and Antioxidant Effects of a Xanthone-Rich Mangosteen (Garcinia mangostana) Product in Humans
Journal of Agricultural and Food Chemistry, October 14, 2009 Issue
This study was designed to determine the overall bioavailability (body readiness) and antioxidant effect of the Vemma formula in the body. This trial took place over a 24-hour period. Participants were separated into two groups, placebo and the Vemma formula. Before the products were consumed, each participant's blood was measured. Then, participants either received a single dose of the Vemma formula or placebo. Blood samples were collected and evaluated. The data concluded that Vemma is highly bioavailable.*
Antioxidant (ORAC) Capacity After Vemma
The antioxidant amounts indicated show how Vemma is highly bioavailable and antioxidant rich compared to the placebo.
Antioxidant (ORAC) Capacity After Vemma
The antioxidant amounts indicated show how Vemma is highly bioavailable and antioxidant rich compared to the placebo.
留言列表
